Gujarat Kidney Super Speciality
MAINBOARD
Listed
Price Band
₹114
Lot Size
127 Shares
Issue Size
₹413.00 Cr
Fresh Issue
₹309.75 Cr
OFS
₹103.25 Cr
Registrar
AI Sentiment Score
Listing Price
₹120.00
vs Issue: ₹114 (+5.26%)
📅 IPO Timeline
✓
Open
Dec 23, 2025
✓
Close
Dec 25, 2025
✓
Allotment
Dec 27, 2025
✓
Refund
Dec 28, 2025
✓
Demat
Dec 28, 2025
✓
Listing
Dec 30, 2025
📈 Grey Market Premium (GMP) Trendline
Daily consensus GMP movement (₹) recorded across market sources
✨ AI Analysis & Prediction
🔒 Final Reconciled Estimate
Locked post-listing with actual debut performance
Gujarat Kidney Super Speciality displays an established operational footprint with expanding revenue streams (23.8% CAGR) and a defensible value proposition.
💪 Strengths
- Demonstrated operational revenue trajectory with resilient top-line growth (23.8% CAGR).
- Established customer relationships and market position across target industry sectors.
- Sound operational capital returns with Return on Capital Employed (ROCE) at 16.5%.
⚠️ Weaknesses
- Exposure to input cost fluctuations and broader macroeconomic supply chain cycles.
- Working capital requirements to support continuous capacity expansion.
- Competitive landscape from both established incumbents and specialized regional players.
🚀 Opportunities
- Industry tailwinds from rising domestic capex and infrastructure spending.
- Operating leverage potential allowing margin expansion as manufacturing utilization rises.
- Geographic diversification and entry into higher-margin specialized product lines.
🛡️ Threats
- Sectoral regulatory shifts and evolving statutory compliance requirements.
- Aggressive pricing actions by domestic competitors impacting gross margins.
- Broader market equity volatility and liquidity fluctuations.
📊 Financial Overview & Growth Trajectory
Multi-year operational scale & net profitability trajectory
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | Rs 412.50 Cr | Rs 495.00 Cr | Rs 632.50 Cr |
| Net Profit / PAT (₹ Cr) | Rs 44.00 Cr | Rs 55.00 Cr | Rs 71.50 Cr |
| EBITDA / Op. Profit (₹ Cr) | Rs 88.00 Cr | Rs 99.00 Cr | Rs 121.00 Cr |
| Borrowings (₹ Cr) | Rs 165.00 Cr | Rs 192.50 Cr | Rs 220.00 Cr |
| Total Assets (₹ Cr) | Rs 825.00 Cr | Rs 990.00 Cr | Rs 1,210.00 Cr |
| ROE % | 0.00% | 0.00% | 0.00% |
| ROCE % | 16.50% | 16.50% | 16.50% |
| Debt / Equity | 0.00 | 0.00 | 0.00 |
Company P/E
24.5x
Industry P/E
28.0x
Debt/Equity
0.45
⚖️ Valuation Benchmark Range
🟢 Attractively Priced vs Industry Peers
Industry 28.0x
IPO 24.5x
0x (Deep Value)
38x (High Multiple)
📋 Live Subscription Status
QIB
0.34x
NII
2.48x
Retail
4.91x
Total
1.51x
🎯 Retail Allotment Probability
20.4% Odds
1 in 4.9 chance (~20.4% probability per PAN)
SEBI Rule: Under SEBI lottery allotment rules, applying for multiple lots under Retail does NOT increase your lottery odds. All valid retail applicants have identical 1-lot odds per PAN.
Updated: Sep 12, 2026 2:33 PM
💼 Issue Structure & Reservation Quota
Capital Structure
₹413.0 Cr
Issue Size
Fresh (75%)
OFS (25%)
Reservation Quota
100%
Allocation
QIB (50%)
NII (15%)
Retail (35%)
QIB
50.00%
Retail
35.00%
NII
15.00%
🔗 Important Links & Lead Managers
- SEBI Filings (DRHP)View on SEBI →
- SEBI Filings (RHP)View on SEBI →
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.